Cargando…
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
Although several studies have explored the molecular landscape of metastatic melanoma, the genetic determinants of therapy resistance are still largely unknown. Here, we aimed to determine the contribution of whole-exome sequencing and circulating free DNA (cfDNA) analysis in predicting response to...
Autores principales: | Vanni, Irene, Pastorino, Lorenza, Tanda, Enrica Teresa, Andreotti, Virginia, Dalmasso, Bruna, Solari, Nicola, Mascherini, Matteo, Cabiddu, Francesco, Guadagno, Antonio, Coco, Simona, Allavena, Eleonora, Bruno, William, Pietra, Gabriella, Croce, Michela, Gangemi, Rosaria, Piana, Michele, Zoppoli, Gabriele, Ferrando, Lorenzo, Spagnolo, Francesco, Queirolo, Paola, Ghiorzo, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002464/ https://www.ncbi.nlm.nih.gov/pubmed/36901733 http://dx.doi.org/10.3390/ijms24054302 |
Ejemplares similares
-
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma
por: Pastorino, Lorenza, et al.
Publicado: (2022) -
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
por: Vanni, Irene, et al.
Publicado: (2020) -
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2017) -
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2018) -
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients
por: Ciccarese, Giulia, et al.
Publicado: (2020)